Association of HLA-C*06:02 Status With Differential Response to Ustekinumab in Patients With Psoriasis: A Systematic Review and Meta-analysis

IMPORTANCE: Previous research showed a differential response to ustekinumab therapy based on HLA-C*06:02 status in patients with psoriasis but consisted mostly of small (and sometimes inconclusive) cohort studies. OBJECTIVE: To assess whether HLA-C*06:02 status is associated with a differential resp...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JAMA Dermatol
Hlavní autoři: van Vugt, Lieke J., van den Reek, Juul M. P. A., Hannink, Gerjon, Coenen, Marieke J. H., de Jong, Elke M. G. J.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Medical Association 2019
Témata:
Original Investigation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6563550/
https://ncbi.nlm.nih.gov/pubmed/30994858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2019.0098
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky